Introduction

akusherstvo

Obstetrics, Gynecology and Reproduction

Акушерство, Гинекология и Репродукция

2313-73472500-3194

IRBIS LLC

10.17749/2313-7347/ob.gyn.rep.2024.571

akusherstvo-2258

Research Article

REVIEW ARTICLES

НАУЧНЫЕ ОБЗОРЫ

Current state of the placenta accreta spectrum issue: prospects for organ-preserving treatment

Современное состояние вопроса placenta accreta spectrum: перспективы органосохраняющего лечения

https://orcid.org/0009-0008-7178-3969

Воронина

М. Д.

Voronina

M. D.

Воронина Марьяна Дмитриевна

344022 Ростов-на-Дону, Нахичеванский переулок, д. 29

Maryana D. Voronina

29 Nahichevansky Lane, Rostov-on-Don 344022

voronina-maryana@list.ru

https://orcid.org/0009-0007-4659-3672

Долгиев

Д. А.

Dolgiev

D. A.

Долгиев Джамалейл Алиханович

344022 Ростов-на-Дону, Нахичеванский переулок, д. 29

Dzhamaleyl A. Dolgiev

29 Nahichevansky Lane, Rostov-on-Don 344022

https://orcid.org/0009-0000-7245-0201

Долгиева

Р. А.

Dolgieva

R. A.

Долгиева Раисхан Алихановна

344022 Ростов-на-Дону, Нахичеванский переулок, д. 29

Raiskhan A. Dolgieva

29 Nahichevansky Lane, Rostov-on-Don 344022

https://orcid.org/0009-0000-2056-2690

Мироваева

А. С.

Mirovaeva

A. S.

Мироваева Анастасия Сергеевна

344022 Ростов-на-Дону, Нахичеванский переулок, д. 29

Anastasiya S. Mirovaeva

29 Nahichevansky Lane, Rostov-on-Don 344022

https://orcid.org/0009-0009-4528-790X

Гараева

З. Ф.

Garaeva

Z. F.

Гараева Залия Фаритовна

426056 Ижевск, ул. Коммунаров, д. 281

Zaliya F. Garaeva

281 Kommunarov Str., Izhevsk 426056

https://orcid.org/0009-0003-2453-6934

Иванова

Ю. К.

Ivanova

Yu. K.

Иванова Юлия Константиновна

197022 Санкт-Петербург, ул. Льва Толстого, д. 6–8

Yulia K. Ivanova

6–8 Lev Tolstoy Str., Saint Petersburg 197022

https://orcid.org/0009-0004-1532-9949

Сарапульцев

И. В.

Sarapultsev

I. V.

Сарапульцев Илья Владимирович

610027 Киров, ул. Карла Маркса, д. 112

Ilya V. Sarapultsev

112 Karl Marks Str., Kirov 610027

https://orcid.org/0009-0007-0171-8961

Турдиева

Е. И.

Turdieva

E. I.

Турдиева Елизавета Игоревна

344022 Ростов-на-Дону, Нахичеванский переулок, д. 29

Elizaveta I. Turdieva

29 Nahichevansky Lane, Rostov-on-Don 344022

https://orcid.org/0009-0005-8888-0501

Раков

В. А.

Rakov

V. A.

Раков Владимир Андреевич

191015, Санкт-Петербург, ул. Кирочная, д. 41

Vladimir A. Rakov

41 Kirochnaya Str., Saint Petersburg 191015

https://orcid.org/0009-0006-9782-6969

Куклина

В. К.

Kuklina

V. K.

Куклина Вероника Константиновна

191015, Санкт-Петербург, ул. Кирочная, д. 41

Veronika K. Kuklina

41 Kirochnaya Str., Saint Petersburg 191015

https://orcid.org/0009-0009-7892-4768

Манелов

А. Е.

Manelov

A. E.

Манелов Александр Евгеньевич

191015, Санкт-Петербург, ул. Кирочная, д. 41

Aleksandr E. Manelov

41 Kirochnaya Str., Saint Petersburg 191015

https://orcid.org/0009-0004-7365-9428

Халилова

К. Х.

Khalilova

K. Kh.

Халилова Кифаят Хаял кызы

443099 Самара, ул. Чапаевская, д. 89

Kifayat Kh. Khalilova

89 Chapaevskaya Str., Samara 443099

ФГБОУ ВО «Ростовский государственный медицинский университет» Министерства здравоохранения Российской ФедерацииРоссияRostov State Medical University, Ministry of Health of the Russian FederationRussian Federation

ФГБОУ ВО «Ижевская государственная медицинская академия» Министерства здравоохранения Российской ФедерацииРоссияIzhevsk State Medical Academy, Ministry of Health of the Russian FederationRussian Federation

ФГБОУ ВО «Первый Санкт-Петербургский государственный медицинский университет имени И.П. Павлова» Министерства здравоохранения Российской ФедерацииРоссияPavlov First Saint Petersburg State Medical University, Ministry of Health of the Russian FederationRussian Federation

ФГБОУ ВО «Кировский государственный медицинский университет» Министерства здравоохранения Российской ФедерацииРоссияKirov State Medical University, Ministry of Health of the Russian FederationRussian Federation

ФГБОУ ВО «Северо-Западный государственный медицинский университет имени И.И. Мечникова» Министерства здравоохранения Российской ФедерацииРоссияMechnikov North-Western State Medical University, Ministry of Health of the Russian FederationRussian Federation

ФГБОУ ВО «Самарский государственный медицинский университет» Министерства здравоохранения Российской ФедерацииРоссияSamara State Medical University, Ministry of Health of the Russian FederationRussian Federation

2025

27112024

1918296

2025

Воронина М.Д., Долгиев Д.А., Долгиева Р.А., Мироваева А.С., Гараева З.Ф., Иванова Ю.К., Сарапульцев И.В., Турдиева Е.И., Раков В.А., Куклина В.К., Манелов А.Е., Халилова К.Х.

Voronina M.D., Dolgiev D.A., Dolgieva R.A., Mirovaeva A.S., Garaeva Z.F., Ivanova Y.K., Sarapultsev I.V., Turdieva E.I., Rakov V.A., Kuklina V.K., Manelov A.E., Khalilova K.K.

Данная работа распространяется под лицензией Creative Commons Attribution 4.0.

This work is licensed under a Creative Commons Attribution 4.0 License.

https://www.gynecology.su/jour/article/view/2258

Introduction

Introduction. Placenta accreta spectrum (PAS) is the preferred term approved by most international organizations that refers to the range of pathologic adherence of the placenta. PAS is a serious problem with incidence rate of 1/272 in-labor women. Today, peripartal hysterectomy is considered as the generally accepted global practice for PAS management, however, this approach is related to high level of maternal mortality and the impossibility of pregnancy in the future.

Aim

Aim: to analyze publications on the available methods for PAS diagnostics and management by highlighting organ-preserving treatment including assessment of relevant risks and benefits compared with other methods as well as prospects for patients.

Materials and Methods

Materials and Methods. Research papers were searched for in the databases eLibrary, PubMed and Google Scholar released until August 2024. The following search queries were used: "placenta accreta spectrum", "PAS", "PAS and organ-preserving treatment", "PAS and peripartum hysterectomy", "PAS and organ-preserving management". The selection of articles was carried out in accordance with the recommendations of PRISMA initiative that allowed to analyze 75 publications included in the review.

Results

Results. Organ-preserving PAS treatment is a reasonable alternative to peripartal hysterectomy, because it provides better results with lower risk to maternal health. It is worth noting that each of these methods has own unique features. For instance, organpreserving treatment may last longer to achieve a desired result, but at the same time it can reduce a risk of complications and improve a woman's quality of life in the long term. Along with this, peripartal hysterectomy may be more effective in the short term, but it is associated with a higher risk of complications.

Conclusion

Conclusion. A doctor should provide a woman with all the necessary information about the risks and benefits of each method, as well as help a woman make an informed decision based on her individual needs and preferences. Organ-preserving PAS treatment contributing to preserve fertility offers a better quality of life with lower risk to maternal health. Ultimately, a choice between peripartal hysterectomy and organ-preserving treatment depends on a specific situation as well as woman's state of health.

Введение

Введение. Предпочтительным термином, одобренным большинством международных организаций, для определения аномальной плацентации всех степеней инвазии является placenta accreta spectrum (PAS). PAS – это серьезная проблема, которая встречается у одной женщины из 272 рожениц. На сегодняшний день общепринятой мировой практикой ведения PAS является перипартальная гистерэктомия, однако этот подход связан с высоким уровнем материнской смертности и невозможностью беременности в будущем.

Цель

Цель: проанализировать литературные данные, посвященные имеющимся методам диагностики и ведения PAS с акцентом на органосохраняющее лечение, включая оценку его рисков и преимуществ по сравнению с другими методами, а также перспективы для пациенток.

Материалы и методы

Материалы и методы. Поиск научных работ проводился в базах данных еLibrary, PubMed и Google Scholar до августа 2024 г. Для поиска использовались следующие поисковые термины на русском и английском языках: «placenta accreta spectrum», «PAS», «PAS и органосохраняющее лечение», «PAS и перипартальная гистерэктомия», «PAS и органосохраняющее ведение», «PAS and organ-preserving treatment», «PAS and peripartum hysterectomy», «PAS and organ-preserving management». Отбор статей осуществлялся в соответствии с рекомендациями PRISMA. В итоге в обзор были включены 75 публикаций.

Результаты

Результаты. Органосохраняющее лечение PAS является разумной альтернативой перипартальной гистерэктомии, так как обеспечивает лучшие результаты с меньшим риском для здоровья матери. Стоит отметить, что каждый из этих методов имеет свои уникальные особенности. Так, органосохраняющее лечение может потребовать больше времени для достижения желаемого результата, но при этом оно может снизить риск осложнений и улучшить качество жизни женщины в долгосрочной перспективе. В то же время перипартальная гистерэктомия может быть более эффективной в краткосрочной перспективе, но она сопряжена с более высоким риском осложнений.

Заключение

Заключение. Врач должен предоставить женщине всю необходимую информацию о рисках и преимуществах каждого метода, а также помочь ей принять обоснованное решение на основе ее индивидуальных потребностей и предпочтений. Органосохраняющее лечение PAS, способствуя сохранению фертильности, обеспечивает более высокое качество жизни с меньшим риском для здоровья матери. В конечном итоге, выбор между перипартальной гистерэктомией и органосохраняющим лечением зависит от конкретной ситуации и состояния здоровья женщины.

placenta accreta spectrumPASгистерэктомияорганосохраняющее лечениеорганосохраняющее ведение

placenta accreta spectrumPAShysterectomyorgan-preserving treatmentorgan-preserving management

References1

Сюндюкова Е.Г., Чуланова Ю.С., Сашенков С.Л. и др. Предлежание и врастание плаценты: вопросы диагностики и акушерской тактики. Российский вестник акушера-гинеколога. 2022;22(3):12–20. https://doi.org/10.17116/rosakush20222203112.

Syundyukova E.G., Chulanova Yu.S., Sashenkov S.L. et al. Placenta previa and placenta accreta: questions of diagnosing and obstetric management. [Predlezhanie i vrastanie placenty: voprosy diagnostiki i akusherskoj taktiki]. Rossijskij vestnik akushera-ginekologa. 2022;22(3):12–20. (In Russ.). https://doi.org/10.17116/rosakush20222203112.

Mogos M.F., Salemi J.L., Ashley M. et al. Recent trends in placenta accreta in the United States and its impact on maternal-fetal morbidity and healthcare-associated costs, 1998–2011. J Matern Fetal Neonatal Med. 2016;29(7):1077–82. https://doi.org/10.3109/14767058.2015.1034103.

Барановская Е.И. Этиология и диагностика placenta accreta. Российский вестник акушера-гинеколога. 2020;20(3):24–8. https://doi.org/10.17116/rosakush20202003124.

Baranovskaya E.I. Etiology and diagnosis of placenta accreta. [Etiologiya i diagnostika placenta accrete]. Rossijskij vestnik akusheraginekologa. 2020;20(3):24–8. (In Russ.). https://doi.org/10.17116/rosakush20202003124.

Лебеденко Е.Ю., Беспалая А.В., Феоктистова Т.Е., Рымашевский М.А. Анализ мировых трендов уровня кесарева сечения с использованием классификации Робсона. Медицинский вестник Юга России. 2021;12(2):16–21. https://doi.org/10.21886/2219-8075-2021-12-2-16-21.

Lebedenko E.Yu., Bespalaya A.V., Feoktistova T.E., Rymashevskiy M.A. Analysis of global trends in caesarean section rates using the Robson classification. [Analiz mirovyh trendov urovnya kesareva secheniya s ispol'zovaniem klassifikacii Robsona]. Medicinskij vestnik Yuga Rossii. 2021;12(2):16–21. (In Russ.). https://doi.org/10.21886/2219-8075-2021-12-2-16-21.

Silver R.M., Branch D.W. Placenta accreta spectrum. N Engl J Med. 2018;378(16):1529–36. https://doi.org/10.1056/NEJMcp1709324.

Silver R.M., Branch D.W. Placenta accreta spectrum. N Engl J Med. 2018;378(16):1529 36. https://doi.org/10.1056/NEJMcp1709324.

Einerson B.D., Gilner J.B., Zuckerwise L.C. Placenta accreta spectrum. Obstet Gynecol. 2023;142(1):31–50. https://doi.org/10.1097/AOG.0000000000005229.

Ernst L.M., Linn R.L., Minturn L., Miller E.S. Placental pathologic associations with morbidly adherent placenta: potential insights into pathogenesis. Pediatr Dev Pathol. 2017;20(5):387–93. https://doi.org/10.1177/1093526617698600.

Jauniaux E., Bhide A., Kennedy A. et al.; FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO consensus guidelines on placenta accreta spectrum disorders: Prenatal diagnosis and screening. Int J Gynaecol Obstet. 2018;140(3):274–80. https://doi.org/10.1002/ijgo.12408.

Jauniaux E., Ayres-de-Campos D., Langhoff-Roos J. et al. FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO classification for the clinical diagnosis of placenta accreta spectrum disorders. Int J Gynaecol Obstet. 2019;146(1):20–4. https://doi.org/10.1002/ijgo.12761.

Yu F.N.Y., Leung K.Y. Antenatal diagnosis of placenta accreta spectrum (PAS) disorders. Best Pract Res Clin Obstet Gynaecol. 2021;72:13–24. https://doi.org/10.1016/j.bpobgyn.2020.06.010.

Carusi D.A., Fox K.A., Lyell D.J. et al. Placenta accreta spectrum without placenta previa. Obstet Gynecol. 2020;136(3):458–65. https://doi.org/10.1097/AOG.0000000000003970.

Sugai S., Yamawaki K., Sekizuka T. et al. Pathologically diagnosed placenta accreta spectrum without placenta previa: a systematic review and meta-analysis. Am J Obstet Gynecol MFM. 2023;5(8):101027. https://doi.org/10.1016/j.ajogmf.2023.101027.

Committee on Obstetric Practice. Committee opinion no. 529: placenta accreta. Obstet Gynecol. 2012;120(1):207–11. https://doi.org/10.1097/AOG.0b013e318262e340.

Jauniaux E., Collins S., Burton G.J. Placenta accreta spectrum: pathophysiology and evidence-based anatomy for prenatal ultrasound imaging. Am J Obstet Gynecol. 2018;218(1):75–87. https://doi.org/10.1016/j.ajog.2017.05.067.

Laoreti A., Thilaganathan B., Agten A.K. et al. Placental thickness in the lower uterine segment and invasive placentation: Will the promise live up? Acta Obstet Gynecol Scand. 2019;98(2):266. https://doi.org/10.1111/aogs.13460.

Familiari A., Liberati M., Lim P. et al. Diagnostic accuracy of magnetic resonance imaging in detecting the severity of abnormal invasive placenta: a systematic review and meta-analysis. Acta Obstet Gynecol Scand. 2018;97(5):507–20. https://doi.org/10.1111/aogs.13258.

Palacios-Jaraquemada J.M., Bruno C.H., Martín E. MRI in the diagnosis and surgical management of abnormal placentation. Acta Obstet Gynecol Scand. 2013;92(4):392–7. https://doi.org/10.1111/j.1600-0412.2012.01527.x.

D'Antonio F., Palacios-Jaraquemada J., Lim P.S. et al. Counseling in fetal medicine: evidence-based answers to clinical questions on morbidly adherent placenta. Ultrasound Obstet Gynecol. 2016;47(3):290–301. https://doi.org/10.1002/uog.14950.

Collins S.L., Alemdar B., van Beekhuizen H.J. et al.; International Society for Abnormally Invasive Placenta (IS-AIP). Evidence-based guidelines for the management of abnormally invasive placenta: recommendations from the International Society for Abnormally Invasive Placenta. Am J Obstet Gynecol. 2019;220(6):511–26. https://doi.org/10.1016/j.ajog.2019.02.054.

Allen L., Jauniaux E., Hobson S. et al. FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO consensus guidelines on placenta accreta spectrum disorders: Nonconservative surgical management. Int J Gynaecol Obstet. 2018;140(3):281–90. https://doi.org/10.1002/ijgo.12409.

Jauniaux E., Bhide A. Prenatal ultrasound diagnosis and outcome of placenta previa accreta after cesarean delivery: a systematic review and meta-analysis. Am J Obstet Gynecol. 2017;217(1):27–36. https://doi.org/10.1016/j.ajog.2017.02.050.

Fitzpatrick K.E., Sellers S., Spark P. et al. The management and outcomes of placenta accreta, increta, and percreta in the UK: a population-based descriptive study. BJOG. 2014;121(1):62–70. https://doi.org/10.1111/1471-0528.12405.

Nieto-Calvache A.J., Palacios-Jaraquemada J.M., Osanan G. et al. Latin American group for the study of placenta accreta spectrum. Lack of experience is a main cause of maternal death in placenta accreta spectrum patients. Acta Obstet Gynecol Scand. 2021;100(8):1445–53. https://doi.org/10.1111/aogs.14163.

Overton E., Wen T., Friedman A.M. et al. Outcomes associated with peripartum hysterectomy in the setting of placenta accreta spectrum disorder. Am J Obstet Gynecol MFM. 2023;5(12):101–174. https://doi.org/10.1016/j.ajogmf.2023.101174.

Bailit J.L., Grobman W.A., Rice M.M. et al.; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units (MFMU) Network. Morbidly adherent placenta treatments and outcomes. Obstet Gynecol. 2015;125(3):683–9. https://doi.org/10.1097/AOG.0000000000000680.

Angstmann T., Gard G., Harrington T. et al. Surgical management of placenta accreta: a cohort series and suggested approach. Am J Obstet Gynecol. 2010;202(1):38.e1-9. https://doi.org/10.1016/j.ajog.2009.08.037.

Shamshirsaz A.A., Fox K.A., Salmanian B. et al. Maternal morbidity in patients with morbidly adherent placenta treated with and without a standardized multidisciplinary approach. Am J Obstet Gynecol. 2015;212(2):218.1–9. https://doi.org/10.1016/j.ajog.2014.08.019.

Eller A.G., Porter T.F., Soisson P., Silver R.M. Optimal management strategies for placenta accreta. BJOG. 2009;116(5):648–54. https://doi.org/10.1111/j.1471-0528.2008.02037.x.

Warshak C.R., Ramos G.A., Eskander R. et al. Effect of predelivery diagnosis in 99 consecutive cases of placenta accreta. Obstet Gynecol. 2010;115(1):65–9. https://doi.org/10.1097/AOG.0b013e3181c4f12a.

Sentilhes L., Kayem G., Mattuizzi A. Conservative approach: Intentional retention of the placenta. Best Pract Res Clin Obstet Gynaecol. 2021;72:52–66. https://doi.org/10.1016/j.bpobgyn.2020.07.010.

Schumann E.A. Pathology of the third stage of labor with especial reference to the placental element. Med Rec Ann. 1940;151:381–4.

Sentilhes L., Deneux-Tharaux C., Seco A., Kayem G. 4: Conservative management versus cesarean hysterectomy for placenta accreta spectrum; the PACCRETA prospective population-based study. Am J Obstet Gynecol. 2020;222(1):S3–S4.

Sentilhes L., Seco A., Azria E. et al.; PACCRETA Study Group. Conservative management or cesarean hysterectomy for placenta accreta spectrum: the PACCRETA prospective study. Am J Obstet Gynecol. 2022;226(6):839.e1– 839.e24. https://doi.org/10.1016/j.ajog.2021.12.013.

Sentilhes L., Seco A., Kayem G., Deneux-Tharaux C. Postdischarge outcomes of readmitted women included in the PACCRETA study. Am J Obstet Gynecol. 2022;227(5):795–8. https://doi.org/10.1016/j.ajog.2022.06.042.

Amsalem H., Kingdom J.C.P., Farine D. et al. Planned caesarean hysterectomy versus "conserving" caesarean section in patients with placenta accreta. J Obstet Gynaecol Can. 2011;33(10):1005–10. https://doi.org/10.1016/S1701-2163(16)35049-6.

Kutuk M.S., Ak M., Ozgun M.T. Leaving the placenta in situ versus conservative and radical surgery in the treatment of placenta accreta spectrum disorders. Int J Gynaecol Obstet. 2018;140(3):338–44. https://doi.org/10.1002/ijgo.12308.

Bouvier A., Sentilhes L., Thouveny F. et al. Planned caesarean in the interventional radiology cath lab to enable immediate uterine artery embolization for the conservative treatment of placenta accreta. Clin Radiol. 2012;67(11):1089–94. https://doi.org/10.1016/j.crad.2012.04.001.

Sentilhes L., Kayem G., Chandraharan E. et al; FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO consensus guidelines on placenta accreta spectrum disorders: Conservative management. Int J Gynaecol Obstet. 2018;140(3):291–8. https://doi.org/10.1002/ijgo.12410.

Soyer P., Sirol M., Fargeaudou Y. et al. Placental vascularity and resorption delay after conservative management of invasive placenta: MR imaging evaluation. Eur Radiol. 2013;23(1):262–71. https://doi.org/10.1007/s00330-012-2573-4.

Pineles B.L., Coselli J., Ghorayeb T. et al. Leaving the placenta in situ in placenta accreta spectrum disorders: a single-center case series. Am J Perinatol. 2024;41(S 01):е420–е429. https://doi.org/10.1055/a-1885-1942.

Pineles B.L., Coselli J., Ghorayeb T. et al. Leaving the placenta in situ in pla- centa accreta spectrum disorders: a single-center case series. Am J Perinatol. 2024;41(S 01):е420–е429. https://doi.org/10.1055/a-1885-1942.

Sentilhes L., Ambroselli C., Kayem G. et al. Maternal outcome after conservative treatment of placenta accreta. Obstet Gynecol. 2010;115(3):526–34. https://doi.org/10.1097/AOG.0b013e3181d066d4.

Legendre G., Zoulovits F.J., Kinn J. et al. Conservative management of placenta accreta: hysteroscopic resection of retained tissues. J Minim Invasive Gynecol. 2014;21(5):910–3. https://doi.org/10.1016/j.jmig.2014.04.004.

Барановская Е.И. Предотвращение массивного кровотечения при placenta accreta. Российский вестник акушера-гинеколога. 2021;21(1):84–7. https://doi.org/10.17116/rosakush20212101184.

Baranouskaya E.I. Prevention of massive bleeding due to placenta accreta. [Predotvrashchenie massivnogo krovotecheniya pri placenta accreta]. Rossijskij vestnik akushera-ginekologa. 2021;21(1):84–7. (In Russ.). https://doi.org/10.17116/rosakush20212101184.

Куликов И.А., Доброхотова Ю.Э., Артемьева К.А. и др. Современный взгляд на тактику лечения беременных с патологическим прикреплением и предлежанием плаценты (обзор литературы). Проблемы репродукции. 2023;29(2):42–50. https://doi.org/10.17116/repro20232902142.

Kulikov I.A., Dobrokhotova Yu.E., Artemyeva K.A. et al. Modern view on the treatment of pregnant women with placenta previa and placenta accreta spectrum (review). [Sovremennyj vzglyad na taktiku lecheniya beremennyh s patologicheskim prikrepleniem i predlezhaniem placenty (obzor literatury)]. Problemy reprodukcii. 2023;29(2):42–50. (In Russ.). https://doi.org/10.17116/repro20232902142.

Taylor F.B., Toh C.H., Hoots W.K. et al.; Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH). Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost. 2001;86(5):1327–30.

Asakura H., Takahashi H., Uchiyama T. et al.; DIC subcommittee of the Japanese Society on Thrombosis and Hemostasis. Proposal for new diagnostic criteria for DIC from the Japanese Society on Thrombosis and Hemostasis. Thromb J. 2016;14:42. https://doi.org/10.1186/s12959-016-0117-x.

Singh N., Sethi A. Endometritis – diagnosis, treatment and its impact on fertility – a scoping review. JBRA Assist Reprod. 2022;26(3):538–46. https://doi.org/10.5935/1518-0557.20220015.

Калинкина О.Б., Тезиков Ю.В., Липатов И.С. и др. Опыт органосохраняющей тактики ведения при врастании плаценты. Медико-фармацевтический журнал "Пульс". 2023;25(6):37–42. https://doi.org/10.26787/nydha-2686-6838-2023-25-6-37-42.

Kalinkina O.B., TezikovYu.V., Lipatov I.S. et al. Experience of organpreserving management tactics for placenta accreta. [Opyt organosohranyayushchej taktiki vedeniya pri vrastanii placenty]. Mediko-farmacevticheskij zhurnal "Pul's". 2023;25(6):37–42. (In Russ.). https://doi.org//10.26787/nydha-2686-6838-2023-25-6-37-42.

Grover B., Einerson B.D., Keenan K.D. et al. Patient-reported health outcomes and quality of life after peripartum hysterectomy for placenta accreta spectrum. Am J Perinatol. 2022;39(3):281–7. https://doi.org/10.1055/s-0040-1715465.

Sentilhes L., Kayem G., Silver R.M. Conservative management of placenta accreta spectrum. Clin Obstet Gynecol. 2018;61(4):783–94. https://doi.org/10.1097/GRF.0000000000000395.

Dahl C.M., Turok D., Heuser C.C. et al. Strategies for obstetricians and gynecologists to advance reproductive autonomy in a post-Roe landscape. Am J Obstet Gynecol. 2024;230(2):226–34. https://doi.org/10.1016/j.ajog.2023.07.055.

Einerson B.D., Watt M.H., Sartori B. et al. Lived experiences of patients with placenta accreta spectrum in Utah: a qualitative study of semistructured interviews. BMJ Open. 2021;11(11):e052766. https://doi.org/10.1136/bmjopen-2021-052766.

Bartels H.C., Horsch A., Cooney N. et al. Living with a diagnosis of Placenta Accreta Spectrum: Mothers' and Fathers' experience of the antenatal journey and the birth. PLoS One. 2023;18(5):e0286082. https://doi.org/10.1371/journal.pone.0286082.

Bartels H.C., Horsch A., Cooney N. et al. Living beyond placenta accreta spectrum: parent's experience of the postnatal journey and recommendations for an integrated care pathway. BMC Pregnancy Childbirth. 2022;22(1):397. https://doi.org/10.1186/s12884-022-04726-8.

Shainker S.A., Cornely R.M., Astake R., Hacker M.R. Patient perception of care, outcomes, and consequences from placenta accreta spectrum: a survey-based study. Am J Perinatol. 2024;41(S 01):е486–е493. https://doi.org/10.1055/a-1905-5079.

Bartels H.C., Lalor J.G., Walsh D. et al. Anesthesia and postpartum pain management for placenta accreta spectrum: the patient perspective and recommendations for care. Int J Gynaecol Obstet. 2024;164(3):992–1000. https://doi.org/10.1002/ijgo.15125.

Abi Habib P., Goetzinger K., Turan O.M. Placenta accreta spectrum conservative management and coagulopathy: case series and systematic review. Ultrasound Obstet Gynecol. 2024;63(6):731–7. https://doi.org/10.1002/uog.27547.

Marcellin L., Delorme P., Bonnet M.P. et al. Placenta percreta is associated with more frequent severe maternal morbidity than placenta accreta. Am J Obstet Gynecol. 2018;219(2):193.e1–193.e9. https://doi.org/10.1016/j.ajog.2018.04.049.

Pather S., Strockyj S., Richards A. et al. Maternal outcome after conservative management of placenta percreta at caesarean section: a report of three cases and a review of the literature. Aust N Z J Obstet Gynaecol. 2014;54(1):84–7. https://doi.org/10.1111/ajo.12149.

Clausen C., Lönn L., Langhoff-Roos J. Management of placenta percreta: a review of published cases. Acta Obstet Gynecol Scand. 2014;93(2):138– 43. https://doi.org/10.1111/aogs.12295.

Youssefzadeh A.C., Matsuzaki S., Mandelbaum R.S. et al. Trends, characteristics, and outcomes of conservative management for placenta percreta. Arch Gynecol Obstet. 2022;306(3):913–20. https://doi.org/10.1007/s00404-021-06384-1.

Sentilhes L., Kayem G., Deneux-Tharaux C. Conservative management or cesarean hysterectomy for placenta percreta? A subgroup analysis of the PACCRETA study is needed. Am J Obstet Gynecol. 2022;227(1):117–8. https://doi.org/10.1016/j.ajog.2022.01.029.

Shamshirsaz A.A., Fox K.A., Erfani H. et al. Multidisciplinary team learning in the management of the morbidly adherent placenta: outcome improvements over time. Am J Obstet Gynecol. 2017;216(6):612.e1– 612.e5. https://doi.org/10.1016/j.ajog.2017.02.016.

Erfani H., Fox K.A., Clark S.L. et al. Maternal outcomes in unexpected placenta accreta spectrum disorders: single-center experience with a multidisciplinary team. Am J Obstet Gynecol. 2019;221(4):337.e1–337.e5. https://doi.org/10.1016/j.ajog.2019.05.035.

Erfani H., Fox K.A., Clark S.L. et al. Maternal outcomes in unexpected placenta accreta spectrum disorders: single-center experience with a multidisciplinary team. Am J Obstet Gynecol. 2019;221(4):337.e1– 337.e5. https://doi.org/10.1016/j.ajog.2019.05.035.

Fitzgerald G.D., Newton J.M., Atasi L. et al. Pan-American Society for Placenta Accreta Spectrum. Placenta accreta spectrum care infrastructure: an evidence-based review of needed resources supporting placenta accreta spectrum care. Am J Obstet Gynecol MFM. 2024;6(1):101229. https://doi.org/10.1016/j.ajogmf.2023.101229.

Silver R.M., Fox K.A., Barton J.R. et al. Center of excellence for placenta accreta. Am J Obstet Gynecol. 2015;212(5):561–8. https://doi.org/10.1016/j.ajog.2014.11.018.

Nawrocki P.S., Levy M., Tang N. et al. Interfacility transport of the pregnant patient: a 5-year retrospective review of a Single Critical Care Transport Program. Prehosp Emerg Care. 2019;23(3):377–84. https://doi.org/10.1080/10903127.2018.1519005.

Sentilhes L., Kayem G., Ambroselli C. et al. Fertility and pregnancy outcomes following conservative treatment for placenta accreta. Hum Reprod. 2010;25(11):2803–10. https://doi.org/10.1093/humrep/deq239.

Salomon L.J., de Tayrac R., Castaigne-Meary V. et al. Fertility and pregnancy outcome following pelvic arterial embolization for severe postpartum haemorrhage. A cohort study. Hum Reprod. 2003;18(4):849–52. https://doi.org/10.1093/humrep/deg168.

Provansal M., Courbiere B., Agostini A. et al. Fertility and obstetric outcome after conservative management of placenta accreta. Int J Gynaecol Obstet. 2010;109(2):147–50. https://doi.org/10.1016/j.ijgo.2009.12.011.

Zhao H., Liu C., Fu H. et al. Subsequent pregnancy outcomes and risk factors following conservative treatment for placenta accreta spectrum: a retrospective cohort study. Am J Obstet Gynecol MFM. 2023;5(12):101189. https://doi.org/10.1016/j.ajogmf.2023.101189.

Kabiri D., Hants Y., Shanwetter N. et al. Outcomes of subsequent pregnancies after conservative treatment for placenta accreta. Int J Gynaecol Obstet. 2014;127(2):206–10. https://doi.org/10.1016/j.ijgo.2014.05.013.

Baldwin H.J., Nippita T.A., Torvaldsen S. et al. Outcomes of subsequent births after placenta accreta spectrum. Obstet Gynecol. 2020;136(4):745– 55. https://doi.org/10.1097/AOG.0000000000004051.

Roeca C., Little S.E., Carusi D.A. Pathologically diagnosed placenta accreta and hemorrhagic morbidity in a subsequent pregnancy. Obstet Gynecol. 2017;129(2):321–6. https://doi.org/10.1097/AOG.0000000000001843.

Javinani A., Qaderi S., Hessami K. et al. Delivery outcomes in the subsequent pregnancy following the conservative management of placenta accreta spectrum disorder: a systematic review and metaanalysis. Am J Obstet Gynecol. 2024;230(5):485–492.e7. https://doi.org/10.1016/j.ajog.2023.10.047.

The authors declare that there are no conflicts of interest present.